Kirilys Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Kirilys General Information

Description

Operator of a biopharmaceutical company intended for the development of multiple-precision oncology assets. The company is developing a drug that has demonstrated potency, selectivity, and anti-tumor efficacy along with very favorable properties for an oral drug, helping clinicians to improve the treatment of multiple cancers and enhance the lives of patients with chronic kidney disease.

Contact Information

Website
www.kirilys.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Pine Street
  • Suite 125
  • San Francisco, CA 94111
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 100 Pine Street
  • Suite 125
  • San Francisco, CA 94111
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kirilys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 04-May-2025 Completed Out of Business
2. Early Stage VC (Series A) 25-Jan-2023 Completed Clinical Trials - Phase 1
1. Seed Round 23-Mar-2022 Completed Pre-Clinical Trials
To view Kirilys’s complete valuation and funding history, request access »

Kirilys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended for the development of multiple-precision oncology assets. The company
Drug Discovery
San Francisco, CA
2 As of 2023

Wuxi, China

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kirilys Competitors (18)

One of Kirilys’s 18 competitors is GeneCast Biotechnology, a Private Equity-Backed company based in Wuxi, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneCast Biotechnology Private Equity-Backed Wuxi, China
Merck & Co. Corporation Rahway, NJ
Exact Sciences Formerly VC-backed Madison, WI
GRAIL Formerly VC-backed Menlo Park, CA
Editas Medicine Formerly VC-backed Cambridge, MA
You’re viewing 5 of 18 competitors. Get the full list »

Kirilys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Kirilys FAQs

  • When was Kirilys founded?

    Kirilys was founded in 2021.

  • Where is Kirilys headquartered?

    Kirilys is headquartered in San Francisco, CA.

  • What is the size of Kirilys?

    Kirilys has 2 total employees.

  • What industry is Kirilys in?

    Kirilys’s primary industry is Drug Discovery.

  • Is Kirilys a private or public company?

    Kirilys is a Private company.

  • What is Kirilys’s current revenue?

    The current revenue for Kirilys is .

  • Who are Kirilys’s competitors?

    GeneCast Biotechnology, Merck & Co., Exact Sciences, GRAIL, and Editas Medicine are some of the 18 competitors of Kirilys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process